Skip to main content

Seagen Inc.

SGENDelisted Dec 14, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001060736

Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Seagen Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Seagen Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Seagen Inc.
NameTitleLast reported holdingLast filingFilings, past year
Baker JulianDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker FelixDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Bros. Advisors LPDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Brothers Life Sciences LPDirector, Other: Former 10% Owner0IndirectDec 18, 20230
667, L.P.Director, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Bros. Advisors (GP) LLCDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Love Ted WDirector0Dec 15, 20230
Gryska David WDirector0Dec 15, 20230
Welch Daniel GDirector0IndirectDec 15, 20230
Simpson Todd EChief Financial Officer0Dec 15, 20230
Liu Jean IChief Legal Officer0Dec 15, 20230
Simonian Nancy ADirector0Dec 15, 20230
Himes Vaughn BChief Technical Officer0IndirectDec 15, 20230
Epstein David RCEO0Dec 15, 20230
Orwin John ADirector0Dec 15, 20230
Seth AlpnaDirector0Dec 15, 20230
Dansey Roger DPresident, R&D & CMO0Dec 15, 20230
Romp Charles REVP, Commercial U.S.0Dec 15, 20230
Swain Sandra MDirector0Dec 15, 20230
Siegall Clay BPresident & CEO666,060May 13, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 6, 2021 (view filing)Jul 24 daysRomp Charles REVP, CommercialSSale−703$158.41−$111.4K−1.6%43.2K after
Jul 6, 2021 (view filing)Jul 1-25 daysSiegall Clay BPresident and CEOSSale−29.4K$157.04−$4.61M−3.9%715.2K after7 lots
Aug 6, 2021 (view filing)Aug 5-61 daySiegall Clay BPresident & CEOSSale−29.4K$162.41−$4.77M−3.9%715.2K after6 lots
Aug 13, 2021 (view filing)Aug 13Same dayDansey Roger DChief Medical OfficerSSale−10.0K$156.59−$1.57M−11.8%74.4K after2 lots
Aug 18, 2021 (view filing)Aug 162 daysSimpson Todd EChief Financial OfficerSSale−533$154.55−$82.4K−0.4%119.3K after
Aug 18, 2021 (view filing)Aug 162 daysLiu Jean IGC/EVP, Leg AffairsSSale−718$154.55−$111.0K−1.1%63.3K after
Aug 18, 2021 (view filing)Aug 162 daysDansey Roger DChief Medical OfficerSSale−1.66K$154.55−$256.1K−2.2%72.8K after
Aug 18, 2021 (view filing)Aug 162 daysHimes Vaughn BChief Technical OfficerSSale−658$154.55−$101.7K−1.2%52.4K after
Aug 18, 2021 (view filing)Aug 162 daysSiegall Clay BPresident & CEOSSale−2.79K$154.55−$431.0K−0.4%712.4K after
Aug 18, 2021 (view filing)Aug 162 daysRomp Charles REVP, CommercialSSale−777$154.55−$120.1K−1.8%42.4K after
Aug 31, 2021 (view filing)Aug 27-314 daysSiegall Clay BPresident and CEOSSale−60.4K$167.90−$10.1M−8.1%682.8K after6 lots
Sep 2, 2021 (view filing)Aug 312 daysRomp Charles REVP, CommercialSSale−1.13K$167.52−$189.8K−2.2%51.2K after2 lots
Sep 2, 2021 (view filing)Aug 312 daysHimes Vaughn BChief Technical OfficerSSale−3.58K$167.52−$600.4K−5.9%57.5K after2 lots
Sep 2, 2021 (view filing)Aug 312 daysSimpson Todd EChief Financial OfficerSSale−3.99K$167.52−$667.9K−3.1%126.4K after2 lots
Sep 2, 2021 (view filing)Aug 312 daysLiu Jean IGC/EVP, Legal AffairsSSale−3.65K$167.52−$611.1K−5.0%68.9K after2 lots
Sep 2, 2021 (view filing)Aug 312 daysSiegall Clay BPresident & CEOSSale−14.4K$167.52−$2.40M−2.1%668.5K after2 lots
Sep 2, 2021 (view filing)Aug 312 daysDansey Roger DChief Medical OfficerSSale−4.61K$167.52−$772.4K−5.1%85.3K after3 lots
Sep 10, 2021 (view filing)Sep 82 daysHimes Vaughn BChief Technical OfficerSSale−6.00K$150.00−$900.0K−9.5%57.5K after
Nov 2, 2021 (view filing)Oct 294 daysSimpson Todd EChief Financial OfficerSSale−33.6K$180.00−$6.04M−20.9%126.6K after
Nov 3, 2021 (view filing)Nov 12 daysLiu Jean IGC/EVP, Leg AfairsSSale−34.9K$177.41−$6.19M−33.5%69.1K after6 lots
Nov 5, 2021 (view filing)Nov 32 daysSimpson Todd EChief Financial OfficerSSale−40.2K$185.00−$7.44M−24.1%126.6K after
Nov 12, 2021 (view filing)Nov 111 dayHimes Vaughn BChief Technical OfficerSSale−6.00K$178.63−$1.07M−9.1%59.8K after3 lots
Dec 2, 2021 (view filing)6:51 PM ETNov 30-Dec 12 daysBaker Julian and 5 othersDirector, 10% OwnerSSale−394.9K$160.54−$63.4M−0.9%42.9M after20 lots
Dec 9, 2021 (view filing)Dec 72 daysSiegall Clay BPresident & CEOSSale−45.4K$148.66−$6.76M−6.4%669.2K after5 lots
Dec 22, 2021 (view filing)Dec 202 daysLiu Jean IChief Legal OfficerSSale−276$149.85−$41.4K−0.4%70.4K after
Dec 22, 2021 (view filing)Dec 202 daysSimpson Todd EChief Financial OfficerSSale−345$149.85−$51.7K−0.3%128.5K after
Dec 22, 2021 (view filing)Dec 202 daysSiegall Clay BPresident & CEOSSale−1.23K$149.85−$183.9K−0.2%667.9K after
Dec 22, 2021 (view filing)Dec 20-212 daysDansey Roger DChief Medical OfficerSSale−560$152.72−$85.5K−0.6%88.4K after2 lots
Dec 22, 2021 (view filing)Dec 202 daysHimes Vaughn BChief Technical OfficerSSale−345$149.85−$51.7K−0.6%59.5K after
Dec 22, 2021 (view filing)Dec 202 daysRomp Charles REVP, CommercialSSale−1.32K$149.85−$198.3K−2.6%50.0K after2 lots
Jan 5, 2022 (view filing)Jan 32 daysDansey Roger DChief Medical OfficerSSale−8.68K$152.58−$1.32M−9.8%79.7K after3 lots
Jan 11, 2022 (view filing)Jan 74 daysSiegall Clay BPresident & CEOSSale−17.0K$144.73−$2.47M−2.5%667.9K after4 lots
Jan 19, 2022 (view filing)Jan 145 daysGryska David WDirectorSSale−4.50K$135.24−$608.6K−8.9%46.3K after
Feb 1, 2022 (view filing)Jan 284 daysGryska David WDirectorSSale−4.50K$122.56−$551.5K−8.9%46.3K after4 lots
Feb 4, 2022 (view filing)Feb 2-32 daysDansey Roger DChief Medical OfficerSSale−1.44K$136.88−$197.4K−1.8%78.2K after2 lots
Feb 9, 2022 (view filing)Feb 72 daysGryska David WDirectorSSale−4.50K$138.76−$624.4K−8.9%46.3K after3 lots
Feb 9, 2022 (view filing)Feb 72 daysSiegall Clay BPresident & CEOSSale−17.0K$139.97−$2.39M−2.5%667.9K after5 lots
Mar 4, 2022 (view filing)Mar 31 dayHimes Vaughn BChief Technical OfficerSSale−12.0K$127.05−$1.52M−16.8%59.5K after2 lots
Mar 9, 2022 (view filing)Mar 72 daysSiegall Clay BPresident & CEOSSale−17.0K$134.35−$2.29M−2.5%667.9K after5 lots
Apr 8, 2022 (view filing)Apr 71 daySiegall Clay BPresident and CEOSSale−17.0K$154.23−$2.63M−2.5%667.9K after7 lots
Apr 21, 2022 (view filing)Apr 192 daysGryska David WDirectorSSale−4.00K$143.95−$575.8K−8.0%46.3K after3 lots
Apr 22, 2022 (view filing)Apr 20-212 daysDansey Roger DChief Medical OfficerSSale−1.44K$144.24−$207.6K−1.8%77.0K after2 lots
Apr 22, 2022 (view filing)Apr 202 daysHimes Vaughn BChief Technical OfficerSSale−574$144.32−$82.8K−1.0%59.1K after
Apr 22, 2022 (view filing)Apr 202 daysRomp Charles REVP, CommercialSSale−319$144.32−$46.0K−0.6%49.8K after
Apr 22, 2022 (view filing)Apr 202 daysLiu Jean IChief Legal OfficerSSale−401$144.32−$57.9K−0.5%75.9K after
Apr 22, 2022 (view filing)Apr 202 daysSimpson Todd EChief Financial OfficerSSale−567$144.32−$81.8K−0.4%127.9K after
Apr 22, 2022 (view filing)Apr 202 daysSiegall Clay BPresident & CEOSSale−1.89K$144.32−$272.0K−0.3%666.1K after
May 13, 2022 (view filing)May 121 daySiegall Clay BPresident & CEOSSale−17.0K$125.69−$2.14M−2.5%666.1K after2 lots
May 18, 2022 (view filing)May 162 daysRomp Charles REVP, CommercialSSale−333$134.21−$44.7K−0.7%49.5K after
May 26, 2022 (view filing)May 242 daysHimes Vaughn BChief Technical OfficerSSale−10.9K$136.79−$1.49M−15.5%59.1K after3 lots